Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases

Journal of the American Society of Nephrology

Volumn 24, Issue 12, 2013, Pages 2081-2095

  Wickman, Larysa ^a   Afshinnia, Farsad ^a   Wang, Su Q ^a   Yang, Yan ^a   Wang, Fei ^a   Chowdhury, Mahboob ^a   Graham, Delia ^a   Hawkins, Jennifer ^a   Nishizono, Ryuzoh ^a   Tanzer, Marie ^a   Wiggins, Jocelyn ^a   Escobar, Guillermo A ^b   Rovin, Bradley ^c   Song, Peter ^a   Gipson, Debbie ^a   Kershaw, David ^a   Wiggins, Roger C ^a,b  

^a Department of Pediatrics and Communicable Diseases ^*  (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEPHRIN; PODOCIN; BIOLOGICAL MARKER; MESSENGER RNA;

ACUTE GLOMERULONEPHRITIS; ADOLESCENT; ADULT; AGED; ALPORT SYNDROME; ANAPHYLACTOID PURPURA; ARTICLE; CELL LOSS; CHILD; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROSIS; NEPHROTIC SYNDROME; PODOCYTE; PODOCYTE DETACHMENT RATE; PODOCYTURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; REMISSION; RENAL REPLACEMENT THERAPY; RENAL SYSTEM PARAMETERS; SCHOOL CHILD; STEROID DEPENDENT NEPHROTIC SYNDROME; STEROID SENSITIVE NEPHROTIC SYNDROME; URINARY TRACT DISEASE; URINE; URINE PODOCYTE; ACUTE DISEASE; GLOMERULUS; LIPOID NEPHROSIS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PODOCYTES; PROTEINURIA; RNA, MESSENGER; YOUNG ADULT;

EID: 84889009158     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013020173     Document Type: Article

References (44)

1. Wiggins RC: The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 71: 1205-1214, 2007
2. Kriz W, Gretz N, Lemley KV: Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int 54: 687-697, 1998
3. Kim YH, GoyalM, Kurnit D,Wharram B, Wiggins J, Holzman L, Kershaw D, Wiggins R: Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60: 957-968, 2001
4. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC: Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952, 2005
5. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 67: 404-419, 2005
6. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99: 342-348, 1997
7. Meyer TW, Bennett PH, Nelson RG: Podocyte number predicts longterm urinary albumin excretion in Pima Indianswith Type II diabetes and microalbuminuria. Diabetologia 42: 1341-1344, 1999
8. Steffes MW, Schmidt D, McCrery R, Basgen JM; International Diabetic Nephropathy Study Group: Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59: 2104-2113, 2001
9. White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi G, Piras G, De Cosmo S, Viberti G: European Study for the Prevention of Renal Disease in Type I diabetes (ESPRIT): Podocyte number in normotensive type I diabetic patients with albuminuria. Diabetes 51: 3083-3089, 2002
10. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A,Myers BD: Podocytopenia and disease severity in IgAnephropathy. Kidney Int 61: 1475-1485, 2002
11. Dalla Vestra M,Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P: Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 52: 1031-1035, 2003
12. WangG, Lai FM, Kwan BC, Lai KB, ChowKM, Li PK, Szeto CC: Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 22: 300-306, 2009
13. Ichikawa I, Ma J, Motojima M, Matsusaka T: Podocyte damage damages podocytes: Autonomous vicious cycle that drives local spread of glomerular sclerosis. Curr Opin Nephrol Hypertens 14: 205-210, 2005
14. Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, Shedden KA, Dysko RC, Wiggins JE, Wiggins RC: Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int 81: 40-55, 2012
15. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M, Chang JW, Wiggins JE, Lienczewski C, Kretzler M, Wiggins RC: Urine podocyte mRNAsmark progression of renal disease. J AmSocNephrol 20: 1041-1052, 2009
16. Fukuda A, Chowdhury MA, Venkatareddy MP, Wang SQ, Nishizono R, Suzuki T, Wickman LT, Wiggins JE, Muchayi T, Fingar D, Shedden KA, Inoki K, Wiggins RC: Growth-dependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol 23: 1351-1363, 2012
17. Fukuda A,Wickman LT, Venkatareddy MP, Wang SQ, Chowdhury MA, Wiggins JE, Shedden KA, Wiggins RC: Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker. Nephrol Dial Transplant 27: 4079-4087, 2012
18. Hara M, Yanagihara T, Itoh M, Matsuno M, Kihara I: Immunohistochemical and urinary markers of podocyte injury. Pediatr Nephrol 12: 43-48, 1998
19. Hara M, Yanagihara T, Takada T, Itoh M, Matsuno M, Yamamoto T, Kihara I: Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol 18: 35-41, 1998
20. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H: The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome. Am J Nephrol 20: 175-179, 2000
21. Hara M, Yanagihara T, Kihara I: Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 89: 342-347, 2001
22. Pätäri A, Forsblom C, Havana M, Taipale H, Groop PH, Holthöfer H: Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes 52: 2969-2974, 2003
23. Vogelmann SU, NelsonWJ, Myers BD, Lemley KV: Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 285: F40-F48, 2003
24. Petermann AT, Pippin J, Krofft R, Blonski M, Griffin S, Durvasula R, Shankland SJ: Viable podocytes detach in experimental diabetic nephropathy: Potential mechanism underlying glomerulosclerosis. Nephron, Exp Nephrol 98: e114-e123, 2004
25. Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T: Apical cell membranes are shed into urine from injured podocytes: A novel phenomenon of podocyte injury. J AmSocNephrol 16: 408-416, 2005
26. Szeto CC, Lai KB, Chow KM, Szeto CY, Yip TW, Woo KS, Li PK, Lai FM: Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Clin Chim Acta 361: 182-190, 2005
27. Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J: Urinary podocyte loss is amore specificmarker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 16: 1733-1741, 2005
28. Hara M, Yanagihara T, Kihara I: Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein- Henoch purpura nephritis. Clin J Am Soc Nephrol 2: 231-238, 2007
29. CamiciM: Urinary detection of podocyte injury. Biomed Pharmacother 61: 245-249, 2007
30. Wang G, Lai FM, Tam LS, Li KM, Lai KB, Chow KM, Li KT, Szeto CC: Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis. J Rheumatol 34: 2358-2364, 2007
31. Wang G, Lai FM, Lai KB, Chow KM, Kwan BC, Li PK, Szeto CC: Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker. Eur J Endocrinol 158: 317-322, 2008
32. Skoberne A, Konieczny A, Schiffer M: Glomerular epithelial cells in the urine: what has to be done to make them worthwhile? Am J Physiol Renal Physiol 296: F230-F241, 2009
33. Hara M, Yamagata K, Tomino Y, Saito A, Hirayama Y, Ogasawara S, Kurosawa H, Sekine S, Yan K: Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: Establishment of a highly sensitive ELISA to detect urinary podocalyxin. Diabetologia 55: 2913- 2919, 2012
34. Asao R, Asanuma K, Kodama F, Akiba-TakagiM,Nagai-Hosoe Y, Seki T, Takeda Y, Ohsawa I, Mano S, Matsuoka K, Kurosawa H, Ogasawara S, Hirayama Y, Sekine S, Horikoshi S, Hara M, Tomino Y: Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy. Clin J Am Soc Nephrol 7: 1385-1393, 2012
35. Craici IM, Wagner SJ, Bailey KR, Fitz-Gibbon PD, Wood-Wentz CM, Turner ST, Hayman SR, White WM, Brost BC, Rose CH, Grande JP, Garovic VD: Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension 61: 1289- 1296, 2013
36. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, CooperME,MitchWE, Brenner BM: Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL. Kidney Int 65: 2309-2320, 2004
37. Levey AS, Cattran D, Friedman A, Miller WG, Sedor J, Tuttle K, Kasiske B, Hostetter T: Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 54: 205-226, 2009
38. Wiggins JE, GoyalM, Sanden SK,WharramBL, Shedden KA,Misek DE, Kuick RD, Wiggins RC: Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: Prevention by calorie restriction. J Am Soc Nephrol 16: 2953-2966, 2005
39. Wiggins JE, Patel S, Shedden K, Goyal M, Wharram B, Martini S, Kretzler M, Wiggins RC: NFkB in the pro-inflammatory, pro-coagulant, pro-fibrotic aging glomerulus. J Am Soc Nephrol 21: 587-597, 2010
40. Gross O, Licht C, Anders HJ, Hoppe B, Beck B, Tönshoff B, Höcker B, Wygoda S, Ehrich JH, Pape L, Konrad M, Rascher W, Dötsch J, Müller- Wiefel DE, Hoyer P, Knebelmann B, Pirson Y, Grunfeld JP, Niaudet P, Cochat P, Heidet L, Lebbah S, Torra R, Friede T, Lange K, Müller GA, Weber M; Study Group Members of the Gesellschaft für Pädiatrische Nephrologie: Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 81: 494-501, 2012
41. Appel D, Kershaw DB, Smeets B, Yuan G, Fuss A, Frye B, Elger M, Kriz W, Floege J, Moeller MJ: Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 20: 333-343, 2009
42. Romagnani P: Kidney regeneration: Any prospects? Contrib Nephrol 170: 228-236, 2011
43. Troyanov S, Roasio L, Pandes M, Herzenberg AM, Cattran DC: Renal pathology in idiopathicmembranous nephropathy: A new perspective. Kidney Int 69: 1641-1648, 2006
44. Heeringa SF, Branten AJ, Deegens JK, Steenbergen E, Wetzels JF: Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy. Nephrol Dial Transplant 22: 2201-2207, 2007